Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | CRNX |
---|---|---|
09:32 ET | 9604 | 43.655 |
09:34 ET | 200 | 43.525 |
09:36 ET | 1518 | 43.71 |
09:38 ET | 731 | 43.88 |
09:39 ET | 200 | 43.93 |
09:43 ET | 2906 | 43.875 |
09:45 ET | 300 | 43.845 |
09:48 ET | 400 | 43.955 |
09:50 ET | 100 | 43.96 |
09:52 ET | 1748 | 43.76 |
09:54 ET | 400 | 43.7525 |
09:56 ET | 200 | 43.775 |
09:57 ET | 450 | 43.82 |
09:59 ET | 100 | 43.785 |
10:01 ET | 3256 | 43.81 |
10:03 ET | 200 | 43.97 |
10:06 ET | 400 | 43.92 |
10:08 ET | 200 | 43.92 |
10:10 ET | 500 | 43.895 |
10:12 ET | 4762 | 43.845 |
10:14 ET | 1136 | 43.91 |
10:15 ET | 1713 | 43.91 |
10:17 ET | 1150 | 44.02 |
10:19 ET | 359 | 43.94 |
10:21 ET | 783 | 43.95 |
10:24 ET | 1936 | 43.92 |
10:26 ET | 200 | 43.86 |
10:28 ET | 2555 | 44.01 |
10:30 ET | 2392 | 44.23 |
10:32 ET | 900 | 44.11 |
10:33 ET | 1306 | 44.07 |
10:35 ET | 6614 | 43.73 |
10:37 ET | 4047 | 43.87 |
10:39 ET | 2600 | 43.885 |
10:42 ET | 700 | 43.805 |
10:44 ET | 400 | 43.65 |
10:46 ET | 200 | 43.64 |
10:48 ET | 200 | 43.6 |
10:51 ET | 400 | 43.465 |
10:55 ET | 300 | 43.455 |
10:57 ET | 241 | 43.31 |
11:00 ET | 6100 | 43.55 |
11:02 ET | 300 | 43.52 |
11:04 ET | 1250 | 43.59 |
11:06 ET | 3500 | 43.54 |
11:08 ET | 300 | 43.5 |
11:09 ET | 700 | 43.56 |
11:11 ET | 2450 | 43.44 |
11:13 ET | 1920 | 43.45 |
11:15 ET | 700 | 43.45 |
11:18 ET | 1550 | 43.215 |
11:22 ET | 2793 | 43.42 |
11:24 ET | 4021 | 43.52 |
11:26 ET | 4736 | 43.455 |
11:29 ET | 1700 | 43.465 |
11:31 ET | 4314 | 43.46 |
11:33 ET | 2327 | 43.49 |
11:36 ET | 800 | 43.51 |
11:38 ET | 1850 | 43.485 |
11:40 ET | 200 | 43.49 |
11:42 ET | 1904 | 43.61 |
11:44 ET | 1600 | 43.57 |
11:45 ET | 700 | 43.52 |
11:47 ET | 1284 | 43.515 |
11:49 ET | 1980 | 43.47 |
11:51 ET | 600 | 43.52 |
11:54 ET | 650 | 43.57 |
11:56 ET | 100 | 43.57 |
11:58 ET | 500 | 43.57 |
12:00 ET | 1658 | 43.655 |
12:02 ET | 600 | 43.65 |
12:03 ET | 831 | 43.61 |
12:05 ET | 300 | 43.655 |
12:07 ET | 494 | 43.59 |
12:09 ET | 800 | 43.535 |
12:14 ET | 535 | 43.52 |
12:16 ET | 600 | 43.455 |
12:18 ET | 1486 | 43.31 |
12:20 ET | 9115 | 43.22 |
12:21 ET | 1400 | 43.34 |
12:23 ET | 800 | 43.34 |
12:25 ET | 573 | 43.305 |
12:27 ET | 100 | 43.37 |
12:30 ET | 924 | 43.39 |
12:32 ET | 1577 | 43.49 |
12:34 ET | 426 | 43.5443 |
12:36 ET | 861 | 43.51 |
12:38 ET | 200 | 43.48 |
12:39 ET | 1300 | 43.275 |
12:41 ET | 3218 | 43.33 |
12:43 ET | 100 | 43.32 |
12:45 ET | 1424 | 43.35 |
12:48 ET | 1319 | 43.37 |
12:50 ET | 398 | 43.39 |
12:52 ET | 200 | 43.3 |
12:54 ET | 200 | 43.24 |
12:56 ET | 2504 | 43.315 |
12:57 ET | 100 | 43.295 |
12:59 ET | 2726 | 43.375 |
01:01 ET | 2737 | 43.4 |
01:03 ET | 4400 | 43.475 |
01:06 ET | 1710 | 43.65 |
01:08 ET | 1314 | 43.81 |
01:10 ET | 900 | 43.825 |
01:12 ET | 800 | 43.9 |
01:14 ET | 1331 | 43.96 |
01:15 ET | 1300 | 43.945 |
01:17 ET | 700 | 43.965 |
01:19 ET | 1700 | 43.995 |
01:21 ET | 2800 | 43.915 |
01:24 ET | 2289 | 43.86 |
01:26 ET | 1700 | 43.855 |
01:28 ET | 2506 | 43.97 |
01:30 ET | 2451 | 43.895 |
01:32 ET | 2005 | 43.73 |
01:33 ET | 900 | 43.79 |
01:35 ET | 2900 | 43.66 |
01:37 ET | 1700 | 43.56 |
01:39 ET | 1009 | 43.59 |
01:42 ET | 1900 | 43.66 |
01:44 ET | 1324 | 43.72 |
01:46 ET | 2050 | 43.81 |
01:48 ET | 1200 | 43.82 |
01:50 ET | 400 | 43.83 |
01:51 ET | 3905 | 43.8 |
01:53 ET | 3900 | 43.84 |
01:55 ET | 2800 | 43.8 |
01:57 ET | 3008 | 43.88 |
02:00 ET | 634 | 43.89 |
02:02 ET | 1557 | 43.925 |
02:04 ET | 1076 | 43.865 |
02:06 ET | 700 | 43.92 |
02:08 ET | 1600 | 43.9 |
02:09 ET | 2108 | 43.91 |
02:11 ET | 100 | 43.935 |
02:13 ET | 1385 | 44.04 |
02:15 ET | 600 | 44.03 |
02:18 ET | 600 | 44.07 |
02:20 ET | 100 | 44.08 |
02:22 ET | 332 | 44.085 |
02:24 ET | 2623 | 43.93 |
02:26 ET | 800 | 44.02 |
02:27 ET | 1000 | 44.09 |
02:29 ET | 1776 | 43.955 |
02:31 ET | 300 | 43.955 |
02:33 ET | 3302 | 44.055 |
02:36 ET | 600 | 44.035 |
02:38 ET | 600 | 44.08 |
02:40 ET | 4961 | 44.12 |
02:42 ET | 200 | 44.12 |
02:44 ET | 1624 | 44.06 |
02:45 ET | 1498 | 44.03 |
02:47 ET | 924 | 44.06 |
02:49 ET | 200 | 44.09 |
02:51 ET | 200 | 44.02 |
02:54 ET | 1019 | 44.02 |
02:56 ET | 200 | 44.02 |
02:58 ET | 9451 | 44.07 |
03:00 ET | 9352 | 44.055 |
03:02 ET | 100 | 44 |
03:03 ET | 1005 | 44.08 |
03:05 ET | 400 | 44.07 |
03:07 ET | 2884 | 44.37 |
03:09 ET | 12384 | 44.3 |
03:12 ET | 6380 | 44.31 |
03:14 ET | 1248 | 44.3 |
03:16 ET | 600 | 44.22 |
03:18 ET | 2331 | 44.19 |
03:20 ET | 5254 | 44.265 |
03:21 ET | 1938 | 44.22 |
03:23 ET | 1306 | 44.19 |
03:25 ET | 300 | 44.1 |
03:27 ET | 2200 | 44.38 |
03:30 ET | 3872 | 44.23 |
03:32 ET | 1680 | 44.22 |
03:34 ET | 2861 | 44.15 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Crinetics Pharmaceuticals Inc | 3.3B | -11.7x | --- |
Dyne Therapeutics Inc | 3.4B | -8.6x | --- |
Vitaspring Biomedical Co. Ltd | 3.1B | 3,311.3x | --- |
Biohaven Ltd | 3.1B | -5.1x | --- |
Immunovant Inc | 3.8B | -13.9x | --- |
Xenon Pharmaceuticals Inc | 2.8B | -14.2x | --- |
Crinetics Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its Paltusotine, an investigational, oral somatostatin receptor type 2 (SST2) agonist, is in Phase 3 clinical development for acromegaly and Phase 2 clinical development for carcinoid syndrome associated with neuroendocrine tumors. It has demonstrated pharmacologic proof-of-concept in a Phase 1 clinical study for CRN04894, an investigational, oral ACTH antagonist, that is in Phase 2 clinical studies for the treatment of congenital adrenal hyperplasia and Cushing's disease. Its drug candidates are orally delivered, small molecule new chemical entities resulting from in-house drug discovery efforts, including other programs addressing a variety of endocrine conditions such as hyperparathyroidism, polycystic kidney disease, Graves' disease, thyroid eye disease, diabetes and obesity.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.3B |
---|---|
Revenue (TTM) | $2.0M |
Shares Outstanding | 78.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.67 |
EPS | $-3.77 |
Book Value | $7.91 |
P/E Ratio | -11.7x |
Price/Sales (TTM) | 1,685.5 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -12,571.38% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.